Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
The patented ExpressArt TRinucleotide priming technology selects for mRNAs and against rRNAs. This selection is based on the compact rRNA structure. This is required for biological rRNA function; therefore it is a universal feature of all rRNAs and degraded rRNA fragments are even enriched in compact structures.
